Position your company in front of the brightest AI Healthcare brains
Platinum sponsor 2020
TPP is a software solutions provider with over 20 years of expertise in delivering software designed to support the effective, efficient and safe provision of healthcare. TPP’s philosophy is to integrate healthcare across communities based on a single Electronic Health Record (EHR) which seamlessly links to our personalised health record app. We are actively embedding AI and Genetic data into patient and clinical apps to provide early detection of non-communicable diseases as well as providing clinicians with effective, proactive tools to manage chronic conditions such as diabetes.
Sponsor or Exhibit
Raise your company’s profile and get in front of the brightest healthcare AI brains, spanning the whole global ecosystem of pharmaceutical, biotech, medtech, clinicians and healthcare providers, insurers, academics and investors.
A good way to work out what will give you the most cost-effective impact is to talk to us.
Get started today, download the sales pack
Want to Sponsor or Partner with us?
EchoNous has taken the lead in creating intelligent medical tools that help medical professionals solve common everyday problems in healthcare. EchoNous was founded in 2016 by CEO Kevin Goodwin, the original point-of-care ultrasound pioneer, and COO Niko Pagoulatos, PhD, a highly regarded innovator in the ultrasound field. Kevin and Niko came together with the same intense passion toward combining narrow artificial intelligence with extremely miniaturized ultrasound hardware focused on clinical specific applications. EchoNous’s engineers first tackled AI-automated measurement of systolic heart function with their handheld ultrasound probe, KOSMOS. More AI-applications are to come.
SkinVision is the leading service for the early detection of skin cancer. With over 1.2 million users in 50+ countries worldwide, we are fighting skin cancer on a global scale. The app is capable of detecting signs of the most common types of cancer, including melanoma, squamous cell carcinoma, basal cell carcinoma, as well as precancerous actinic keratosis.
So far, we have helped in the discovery of over 35,000 skin cancer cases. Our clinically-validated machine-learning algorithm was developed by mathematicians and dermatologists and builds on the experience from assessing over three million photos. Today, we are on a mission to save 250,000 lives in the next decade.
With over 12 years working within healthcare, Aire Logic is a well-rounded and experienced healthcare IT companies, providing strategic technical consultancy covering enterprise and solution architecture, interoperability and health care standards, agile development best practice advice. It’s staff channel the overarching principles to use digital innovation that improves the efficiency of health and social care and delivers better patient experience and outcomes. Leading substantial programs Healthcare strategy and Enterprise Architecture for Ministry of Health Holdings, Singapore, NHS England, and a record of frontline solutions including development services for Leeds Teaching Hospitals Trust, to consultancy for Claire House Liverpool.
Kheiron Medical Technologies is a leading applied science company, transforming cancer diagnostics through the power of deep learning. Our award winning AI breast screening solution is called Mia™ and we work with world renowned breast radiologists to demonstrate Mia’s™ performance through robust, independent, global studies. Clinical rigour, not hype, is our motto, ensuring our solutions support radiologists to confidently detect breast cancer – giving every woman a better fighting chance.
Alpha is a long term innovation facility established by Telefonica to work on audacious projects on the edge of what is technically possible.
Alpha’s first moonshot, Alpha Health, aims to radically reduce the burden that chronic diseases place on individuals, families, and societies by helping people take more conscious control of their actions.
It does this by bringing together cutting-edge knowledge and research on human behaviour with best-in-class machine learning and product design, aiming to encourage behaviour changes.
Curo-Health is implementing VALUE BASED CARE projects across Europe and Asia with special focus on EMERGING MARKETS. Our mission is to measure and improve patient relevant outcomes. Producing best possible outcome at lowest possible costs. Curo-Heath is the license holder of HOLMUSK.COM products to support our clients with extracting actional insights from REAL WORLD DATA sets. Curo-Health HQ is in Basel, Switzerland.
Oxford Immune Algorithmics (OIA)
Oxford Immune Algorithmics (OIA) is an Oxford University startup and biotech company driven by deep research that builds upon and creates responsible Artificial Intelligence technology to develop a full-stack solution for remote blood testing and health monitoring. Enabled by the synergy of human experts and super-human model-driven AI, we created Algocyte, our flagship product to help healthcare professionals better monitor patients, reduce costs, and make decisions based on personalised medicine. We achieve this by rethinking how to exploit data and repurpose electronic components augmented by AI to develop cutting-edge monitoring technology.
Skin Analytics formed in 2012 with the goal of helping more people survive skin cancer.
We have crafted a series of AI algorithms that can take a dermascopic image of a skin lesion and help identify skin cancer.
We have spent considerable time consulting with experts in the field of skin cancer including clinical researchers, dermatologists and GP’s to make sure that we created a product with real clinical utility.
Holmusk is a DATA ANALYTICS company, using REAL WORLD EVIDENCE (RWE) to improve chronic diseases. Holmusk has built the world’s largest RWE platform for MENTAL HEALT and believes data to be a core utility in healthcare. Holmusk’s RWE platform enables new insights to provision of care and drug development through machine learning, deep learning and digital tools. Its innovative, scalable and cost-effective digital behaviour change programs are designed to nudge people towards better health.
Holmusk is named Technology Pioneer 2019 by the WORLD ECONOMIC FORUM
“The Intelligent Health summit was energizing, uplifting and educational! It was the best of AI without the hype – truly about how AI can impact and improve the health of all people, across diverse geographies, diseases and resources. It was exciting to see how many clinicians participated.”
Dr. Mimi Huizinga, Vice President, Strategic Data and Digital, US Oncology, Novartis
“Intelligent Health 2018 has proven to be the right platform for us to address our Health target audience in terms of level and function. The content shared by an impressive speaker line-up had great quality.”
Anne O’Riordan, Senior Managing Director Life Sciences, Accenture
“It was excellent to partner with Intelligent Health 2018 to ensure a strong focus on leveraging AI for child & adolescent health... and to coordinate our efforts so that AI serves all of humanity”
Stefan Germann, CEO, Fondation Botnar
Don’t miss a thing!
Subscribe to the IH mailing list to be the first to receive the latest news, articles and reports, speakers announcements, programme updates, ticket sales and much more…